Bimatoprost ophthalmic solution 0.03% lowered intraocular pressure of normal-tension glaucoma with minimal adverse events

PURPOSE: The aim of this study was to evaluate the efficacy and safety of bimatoprost ophthalmic solution 0.03% (bimatoprost) in Japanese normal-tension glaucoma (NTG) patients with an intraocular pressure (IOP) of 18 mmHg or less. METHODS: Bimatoprost was instilled into the unilateral conjunctival...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsumura, Toyoaki, Yoshikawa, Keiji, Suzumura, Hirotaka, Kimura, Tairo, Sasaki, Satoshi, Kimura, Itaru, Takeda, Ryuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460718/
https://www.ncbi.nlm.nih.gov/pubmed/23055677
http://dx.doi.org/10.2147/OPTH.S36628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460718/
https://www.ncbi.nlm.nih.gov/pubmed/23055677
http://dx.doi.org/10.2147/OPTH.S36628

Ejemplares similares